The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials

Authors:

Abstract
(2011). The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials. Expert Opinion on Investigational Drugs: Vol. 20, No. 12, pp. 1677-1684.

This publication has 54 references indexed in Scilit: